Skip to main content
OpenTrials

Clinical trial condition

IgA Nephropathy (IgAN)

Explore clinical trials studying IgA Nephropathy (IgAN). Study availability and eligibility vary by location and protocol.

32 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

IgA Nephropathy (IgAN) trial results

Recruiting

Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

NCT06989359

Conditions
Autoimmune Diseases, C3G, Complement-mediated Kidney Disease, +13 more
Locations
  • ADARx Clinical Site Doral, Florida, United States
  • ADARx Clinical Site Miami, Florida, United States
  • ADARx Clinical Site Pembroke Pines, Florida, United States
  • ADARx Clinical Site Iowa City, Iowa, United States
View all 34 locations
View Trial Details
Recruiting

Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN

NCT07390123

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Huangshan City People's Hospital Huangshan City, Anhui, China
  • The Second Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Zhanjiang Central Hospital Zhanjiang, Guangdong, China
View Trial Details

Related conditions